Figure 1: An ORF-based functional screen identifies COT and C-RAF kinases as drivers of resistance to B-RAF inhibition B-RAF mutations are found in ∼8% of all cancers and at high frequencies in ...
This is the product's overall performance score, based on key tests conducted by our industry experts in the CHOICE labs.
This is the product's overall performance score, based on key tests conducted by our industry experts in the CHOICE labs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback